GENEVA, July 18 -- HANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD. filed a patent application (CN2026/071187) for “CD24 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF”. With publication no. WO/2026/149443, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....